FCRL1 and gestational diabetes: The dysregulated metabolic biomarkers identified in the GDM-M group in this study (CLUL1, VCAN, FCRL1 and RNASE3) may reflect heterogeneous physiological and pathological processes linked to the fetal development and metabolism.